Pharmaceutical Technology3 小时
Nivolumab by Bristol-Myers Squibb for Paranasal Sinus And Nasal Cavity Cancer: Likelihood ...
Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.
news.marketersmedia13 天
Spring, TX FDA-Approved Sleep Apnea Treatment: Implant Device Announced
Spring-based Texas Sinus & Snoring (346-413-9313) announces an innovative new treatment for obstructive sleep apnea, ...